These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15487877)

  • 1. Journal club 101 for the new practitioner: evaluation of a clinical trial.
    Askew JP
    Am J Health Syst Pharm; 2004 Sep; 61(18):1885-7. PubMed ID: 15487877
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of new drugs].
    Lewis PJ
    Rev Prat; 1982 Sep; 32(41-42):2649-50 passim. PubMed ID: 7146802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical drug trials. 1: The 4 phases of clinical trials].
    Gleiter CH; Bieck PR
    Fortschr Med; 1991 Feb; 109(5):136-7. PubMed ID: 2045036
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on 'Sample size for equivalence trials: a case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona.
    Sun X; Li X; Chen J
    Stat Med; 2012 Jul; 31(15):1652-3; author reply 1654. PubMed ID: 22711252
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacodynamic modelling. Application to new drug development.
    Kroboth PD; Schmith VD; Smith RB
    Clin Pharmacokinet; 1991 Feb; 20(2):91-8. PubMed ID: 2029808
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of drugs].
    Wasielewski S
    Med Monatsschr Pharm; 1992 Feb; 15(2):34. PubMed ID: 1579074
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of composite endpoints in clinical trials.
    Sankoh AJ; Li H; D'Agostino RB
    Stat Med; 2016 Jan; 35(2):319-20. PubMed ID: 26767752
    [No Abstract]   [Full Text] [Related]  

  • 8. [General modality for evaluation of drugs in pediatry].
    Autret E
    Arch Fr Pediatr; 1990 Nov; 47(9):627-8. PubMed ID: 2078119
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled trial methodology and progress in treatment of the acquired immunodeficiency syndrome (AIDS). A quid pro quo.
    Broder S
    Ann Intern Med; 1989 Mar; 110(6):417-8. PubMed ID: 2919847
    [No Abstract]   [Full Text] [Related]  

  • 10. A consideration of the guidelines for investigating potential new drugs in humans in the United Kingdom.
    McGillion FB
    Methods Find Exp Clin Pharmacol; 1979 Apr; 1(1):45-50. PubMed ID: 552581
    [No Abstract]   [Full Text] [Related]  

  • 11. When to test new drugs in chemosensitive tumors?
    Stoter G
    Ann Oncol; 1992 Feb; 3(2):102. PubMed ID: 1606079
    [No Abstract]   [Full Text] [Related]  

  • 12. [Protocol for the clinical pharmacology study of the hypnotic properties of a drug].
    Allain H; Milon D; van den Driessche J
    Therapie; 1984; 39(1):13-6. PubMed ID: 6463940
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on 'Sample size for equivalence trials: A case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona, Statistics in Medicine 2008; 27:3743-3754.
    Kohberger RC
    Stat Med; 2009 Jan; 28(1):177-8, author reply 178-9. PubMed ID: 18937271
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug regulation: quo vadis?
    Goyan JE
    JAMA; 1988 Nov; 260(20):3052-3. PubMed ID: 3184370
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy measures: surrogates or clinical outcomes?
    Blue JW; Colburn WA
    J Clin Pharmacol; 1996 Sep; 36(9):767-70. PubMed ID: 8889896
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA introductory comments: clinical studies design and evaluation issues.
    Woodcock J
    Clin Trials; 2005; 2(4):273-5. PubMed ID: 16281424
    [No Abstract]   [Full Text] [Related]  

  • 17. Traditional design does not choose values around 33%.
    Ivanova A
    Control Clin Trials; 2002 Apr; 23(2):183. PubMed ID: 11943446
    [No Abstract]   [Full Text] [Related]  

  • 18. The Cancer Therapy Evaluation Program of the National Cancer Institute.
    Muggia FM; Carter SK; Macdonald JS
    Semin Oncol; 1981 Dec; 8(4):394-402. PubMed ID: 7323811
    [No Abstract]   [Full Text] [Related]  

  • 19. Underrepresentation of women in clinical drug trials.
    Schmucker DL; Vesell ES
    Clin Pharmacol Ther; 1993 Jul; 54(1):11-5. PubMed ID: 8330458
    [No Abstract]   [Full Text] [Related]  

  • 20. Methodology of clinical trials on new drugs in epilepsy.
    Morselli PL
    Funct Neurol; 1986; 1(4):503-11. PubMed ID: 3609878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.